Clinical Trials Directory

Trials / Completed

CompletedNCT03870724

Women and Risk of Type 2 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
383 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
Female
Age
27 Years – 60 Years
Healthy volunteers
Accepted

Summary

This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related health issues in pregnancy in a multiethnic population. The investigators will now update the information about the health status of these women to study the development of risk factors for type 2 diabetes and cardiovascular diseases.

Detailed description

The STORK-Groruddalen is a cohort study of 823 pregnant women. Participation rate was high due to facilitation for ethnic minorities and data collection at the local Health Centres, set up to study ethnic differences in health to inform prevention strategies to reduce these differences. The investigators have published many papers from this well charatertized cohort, about gestational diabetes and related health issues in pregnancy. Participants have agreed to be contacted for subsequent follow-up surveys. The inivestigators are now planning a follow-up study of these woman during 2019-2022, to study trajectories for risk factors for type 2 diabetes and cardiovascular diseases such as BMI, blood pressure, lipids, behavioural factors, physical activity and mental health and other health issues. The investigators will collect selfreported information through questionnaires, perform clinical measurements and take blood samples and buccal swabs. Collecting updated information about a range of health outcomes for women in this cohort will, together with already collected data, enable us to study the development of risk factors for type 2 diabetes and cardiovascular diseases in a life course perspective.

Conditions

Timeline

Start date
2019-08-27
Primary completion
2022-03-30
Completion
2022-03-30
First posted
2019-03-12
Last updated
2022-11-03

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03870724. Inclusion in this directory is not an endorsement.